2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors
10.3760/cma.j.issn.0529-5815.2018.11.003
- VernacularTitle: 2017欧洲神经内分泌肿瘤学会共识解读：胰腺神经内分泌瘤诊治更新要点
- Author:
Heli GAO
1
;
Liang LIU
;
Wenquan WANG
;
Xianjun YU
Author Information
1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Neuroendocrine tumors;
Treatment
- From:
Chinese Journal of Surgery
2018;56(11):809-812
- CountryChina
- Language:Chinese
-
Abstract:
Neuroendocrine tumors(NET) is a rare tumor with high heterogeneity.Pancreatic NET is the most common type in China. European Neuroendocrine Tumor Society(ENETS) has launched the ENETS guidelines since 2006 and published the ENETS standard of care in 2009. With the newly targeted therapies and further research on NET, 2017 new edition of the ENETS standard of care has changed a lot in the diagnosis and treatment of NET. This article explains the update of pancreatic NET in the 2017 edition of the ENETS standard of care, and introduces pancreatic NET from pathology, imaging examination, surgery, systemic therapy, etc., and deepens the understanding of the diagnosis and treatment of pancreatic NET.
